Can a person have a mood disorder together with depression and anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can You Have a Mood Disorder and Depression and Anxiety?

Yes, a person can absolutely have a mood disorder together with depression and anxiety—in fact, this co-occurrence is extremely common and clinically significant. Depression itself is a mood disorder, and 50-60% of individuals with a diagnosed depressive disorder will have a comorbid anxiety disorder, with generalized anxiety disorder (GAD) being the most prevalent 1.

Understanding the Co-occurrence

The Clinical Reality

The co-occurrence of mood and anxiety disorders is not just possible—it's the norm rather than the exception:

  • Depression and anxiety frequently co-exist at both the disorder and symptom levels 2
  • A systematic review and meta-analysis found robust evidence of comorbidity between mood and anxiety disorders, with a median odds ratio of 6.1 (range 1.5-18.7) across 90 separate analyses 2
  • All 90 pooled estimates showed positive associations, and 87 were statistically significant, with 14 showing odds ratios greater than 10 2

Clinical Implications

When depression and anxiety co-occur, the clinical picture becomes more complex:

  • Patients experience heightened symptom distress and maladaptive coping 1
  • There is increased risk for treatment resistance 3
  • Higher rates of substance use disorders often accompany this comorbidity 3
  • Poorer quality of life and increased functional impairment result 1
  • Increased mortality risk, including higher suicide rates 1

Screening and Assessment Approach

Initial Screening Protocol

Screen for both conditions systematically 1, 4:

  1. For depression: Use the PHQ-9 as the first-line screening tool

    • Scores ≥10 indicate moderate depression requiring further assessment
    • Scores ≥15 indicate severe depression

  2. For anxiety: Use the GAD-7 scale

    • Scores 5-9: mild anxiety
    • Scores 10-14: moderate anxiety
    • Scores 15-21: severe anxiety

When to Screen

Screen at these critical timepoints 4:

  • Initial diagnosis
  • Start of treatment
  • Regular intervals during treatment
  • End of treatment/transition to survivorship
  • At recurrence or progression
  • During personal crises or transitions
  • When approaching end-of-life care

Diagnostic Assessment

If moderate to severe symptoms are detected, conduct a full diagnostic assessment to:

  • Identify the nature and extent of both depressive and anxiety symptoms 1, 4
  • Determine the presence or absence of formal mood and anxiety disorder diagnoses
  • Rule out medical or substance-induced causes (e.g., interferon administration, electrolyte imbalances, infections) 1

Treatment Considerations

Treatment Hierarchy

When both depression and anxiety are present, the usual practice is to treat the depression first 1. This is because:

  • Antidepressants often improve both conditions
  • Treating depression may reduce anxiety symptoms secondarily
  • Many antidepressants have FDA approval for both conditions

Treatment Options

Use pharmacologic and/or non-pharmacologic interventions 1:

Pharmacologic:

  • No specific antidepressant is superior to another
  • Choose based on: adverse effect profile, drug interactions, prior treatment response, and patient preference
  • Warn patients about potential adverse effects

Non-pharmacologic:

  • Psychotherapy (cognitive-behavioral therapy, psychoeducational therapy)
  • Exercise programs
  • Interventions should be delivered by appropriately trained professionals

Emergency Situations

Immediate psychiatric referral is required for 1, 4:

  • Risk of harm to self or others
  • Severe depression or agitation
  • Presence of psychosis
  • Confusion or delirium

Follow-up and Monitoring

Reassess biweekly or monthly until symptoms remit 1:

  • Monitor treatment compliance and satisfaction
  • Assess for adverse effects
  • After 8 weeks, if symptoms persist despite good compliance, alter the treatment course (add interventions, change medications, or refer for specialized psychotherapy) 1

Common Pitfalls to Avoid

  1. Underdiagnosis: Anxiety disorders are frequently missed when depression is the presenting complaint—always screen for both 1

  2. Inadequate dosing: Even when medications are prescribed, doses are often inadequate 1

  3. Ignoring the anxiety component: Failing to address comorbid anxiety can lead to treatment resistance and poorer outcomes 3

  4. Missing substance use: Anxiety and mood symptoms can be masked by or contribute to substance use disorders 3

  5. Assuming symptoms will resolve together: While treating depression first is standard, some patients require specific anxiety-targeted interventions

The evidence is clear and consistent: mood disorders, depression, and anxiety not only can co-occur—they frequently do, and this comorbidity requires systematic screening, comprehensive assessment, and integrated treatment approaches to optimize patient outcomes.

References

3
Research

Classification of mood disorders.

Psychiatria polska, 2015

Related Questions

What labs should be checked for sudden mood changes?
What are the first‑line medications, typical doses, dosing frequency, and recommended treatment duration for common adult mental health disorders such as major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive‑compulsive disorder, post‑traumatic stress disorder, bipolar depression, acute mania, schizophrenia, and adult attention‑deficit/hyperactivity disorder?
In a 21-year-old woman with a history of anxiety and depressive mood who previously took fluoxetine (Prozac) as an adolescent but has been medication-free for over a year, what is the first-line pharmacologic treatment and appropriate starting dose?
For major depressive disorder (MDD), what is the minimum duration of symptoms required for diagnosis?
What are the key risk factors for major depressive disorder, anxiety disorders, anorexia nervosa, and binge drinking, and is hydroxyzine or propranolol the more appropriate medication for treatment?
What brand of meningococcal conjugate vaccine (MCV4) is recommended for the first dose in an 11‑year‑old male?
Can gabapentin be used to treat menopausal symptoms such as hot flashes and sleep disturbances, and what are the appropriate dosing and safety considerations?
Is it safe to miss a single 50 mg dose of sertraline and change the dosing time from night to morning?
A 67-year-old male cannot swallow the metronidazole pill for Helicobacter pylori infection; what formulation or alternative therapy can be prescribed?
I am experiencing a headache after switching my sertraline (Zoloft) to a morning dose of 50 mg; how should I manage it?
Can a 67-year-old man who cannot swallow tablets be treated with bismuth‑quadruple therapy that includes metronidazole, and what alternatives are available?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.